Human-Derived Cellular Components in Cosmetic Applications: Mechanisms, Formulation, and Future Perspectives

Abstract

In contemporary beauty research, human-derived cellular components have become sophisticated bioactive substances with great potential for anti-aging and skin regeneration [1-3]. These elements, which include fibroblasts and conditioned media, are abundant in extracellular matrix proteins, growth factors, and cytokines that are essential for boosting collagen synthesis, encouraging cellular proliferation, and enhancing skin moisture [4-6]. The molecular mechanisms behind their activity are thoroughly covered in this review, with a focus on pathways related to oxidative stress and tissue repair. reduction, and dermal remodelling[5,7]. In addition, along with important formulation issues for preserving stability and efficacy, the article covers their varied applications in cosmetic formulations, including serums, creams, and skin restoration treatments. The usage of materials produced from humans is also severely assessed in terms of safety, ethical issues, and regulatory considerations. Additionally, new alternatives are investigated as potential avenues for cosmetic innovation in the future, such as biomimetic peptides and plant-derived stem cells [22–24]. All things considered, the development of next-generation cosmeceuticals using human-derived cellular components is a promising strategy, but rigorous assessment of safety and regulatory compliance is still crucial.

Introduction

This review examines the use of human fetal cell-derived components in cosmetic and cosmeceutical products, focusing on their biological functions, applications, formulation challenges, and associated ethical and safety considerations. Advances in biotechnology have enabled the incorporation of bioactive substances into skincare products to improve skin regeneration, anti-aging effects, and wound healing beyond what conventional cosmetic ingredients can achieve.

The primary human-derived components discussed include:

• Fetal fibroblasts, which produce collagen, hyaluronic acid, and extracellular matrix proteins that support scarless healing and skin regeneration.
• Stem cell-derived extracts, containing growth factors (such as EGF, FGF, and TGF-β) and cytokines that stimulate collagen synthesis, cell proliferation, tissue repair, and reduce inflammation.
• Conditioned media, a cell-free mixture of growth factors, exosomes, cytokines, and extracellular matrix proteins that can be stabilized and incorporated into cosmetic formulations using delivery systems such as liposomes and nanospheres.

These bioactive components promote skin health through several mechanisms:

• Stimulating collagen production by activating growth factor signaling pathways, improving skin firmness and reducing wrinkles.
• Enhancing cell regeneration by accelerating fibroblast and keratinocyte proliferation, leading to improved skin repair and faster wound healing.
• Providing anti-aging benefits by increasing extracellular matrix production, reducing oxidative stress, and improving skin elasticity.
• Improving skin hydration by strengthening the skin barrier, increasing natural moisturizing factors, and reducing water loss.

The review highlights their application in a wide range of cosmetic products, including:

• Anti-aging creams that improve firmness and reduce fine lines.
• Serums and essences that deliver concentrated growth factors for skin rejuvenation.
• Skin repair formulations used after environmental damage or cosmetic procedures.
• Scar and wound healing products that promote tissue regeneration and minimize scar formation.

Because these ingredients are biologically sensitive, formulation requires careful consideration of stability, compatibility, and preservation. Growth factors and proteins are susceptible to degradation from heat, light, oxidation, and unsuitable pH conditions. Techniques such as encapsulation, liposomal delivery, and controlled manufacturing conditions are essential to maintain product efficacy. Compatibility with other cosmetic ingredients and appropriate preservation methods are also critical to prevent loss of activity and microbial contamination.

Despite their promising regenerative and anti-aging properties, the review notes that the use of fetal cell-derived materials raises important ethical, legal, regulatory, and public acceptance issues. Continued research is needed to improve formulation technologies, ensure long-term safety, and address ethical concerns while expanding the use of these advanced bioactive ingredients in cosmetic science.

Conclusion

Human-derived cellular components offer novel approaches to skin regeneration and anti-aging applications, marking a major breakthrough in cosmetic research. Their abundance of growth factors, cytokines, and extracellular matrix proteins promotes better cellular proliferation, increased collagen synthesis, and efficient dermal remodeling, which results in noticeable changes in the texture, elasticity, and moisture of the skin. These bioactive ingredients\' increasing significance in contemporary cosmeceuticals is demonstrated by their incorporation into cosmetic formulations such serums, creams, and repair treatments. The use of human-derived materials presents significant safety, ethical, and regulatory issues that must be carefully addressed to assure consumer protection and compliance with international standards, notwithstanding their apparent usefulness. These delicate biomolecules are now more stable and delivered thanks to formulation technology advancements, but more study is needed to maximize their long-term safety and effectiveness. Future prospects in this field are focused on the creation of safer and more sustainable substitutes, such as biomimetic substances and stem cells generated from plants, which might provide similar advantages with less moral dilemmas. All things considered, human-derived cellular components have a great deal of potential to influence next-generation cosmetics—as long as scientific advancement is matched with moral obligation and legal compliance.

References

[1] Kim DH, Lee SY, Kim SM. Effects of growth factors on skin regeneration. J Dermatol Sci. 2019;95(2):85–92. [2] Lee HJ, Lim IJ, Lee MC. The role of fibroblasts in skin aging and repair. Int J Mol Sci. 2016;17(3):456–462. [3] Uitto J. The role of collagen in skin aging. J Invest Dermatol. 2008;128(6):1415–1417. [4] Quan T, Fisher GJ. Role of age-associated alterations in dermal fibroblasts. J Invest Dermatol. 2015;135(2):464–471. [5] Rittié L, Fisher GJ. Natural and sun-induced aging of human skin. Cold Spring Harb Perspect Med. 2015;5(1):a015370. [6] Park BS, Jang KA, Sung JH. Adipose-derived stem cells and their secretory factors in skin rejuvenation. Dermatol Surg. 2008;34(10):1323–1326. [7] Kim WS, Park BS, Sung JH. Wound healing effect of adipose-derived stem cells. J Dermatol Sci. 2007;48(1):15–24. [8] Chen L, Tredget EE, Wu PY. Paracrine factors of stem cells in wound healing. J Cell Physiol. 2008;217(3):749–758. [9] Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835–870. [10] Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in wound healing. Wound Repair Regen. 1996;4(4):411–420. [11] Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127(3):514–525. [12] Gurtner GC, Werner S, Barrandon Y. Wound repair and regeneration. Nature. 2008;453(7193):314–321. [13] Shukla A, Rasik AM, Dhawan BN. Growth factors in wound healing. Indian J Exp Biol. 1999;37(3):247–254. [14] Phan TT, Lim IJ, Aalami O. Fetal fibroblasts exhibit enhanced healing properties. J Cell Biol. 2001;152(5):1119–1128. [15] Lorenz HP, Longaker MT. Scarless skin wound repair in the fetus. N Engl J Med. 2008;339(12):813–817. [16] Pipino C, Pandolfi A. Role of human fibroblasts in tissue regeneration and repair. Int J Mol Sci. 2015;16(5):11607–11623. [17] Fuchs E. Skin stem cells and their role in regeneration. Nature. 2007;445(7130):834–842. [18] Blanpain C, Fuchs E. Epidermal homeostasis and regeneration. Annu Rev Cell Dev Biol. 2009;25:163–192. [19] Ghazizadeh S, Taichman LB. Organization of stem cells in human epidermis. J Invest Dermatol. 2005;124(2):367–372. [20] Proksch E, Brandner JM, Jensen JM. Skin barrier function and repair. Exp Dermatol. 2008;17(12):1063–1072. [21] Lintner K, Peschard O. Biologically active peptides in cosmetic formulations. Int J Cosmet Sci. 2000;22(3):207–218. [22] Farris PK. Cosmeceutical growth factors: scientific evidence and clinical applications. Clin Dermatol. 2009;27(5):502–07. [23] Gold MH. Use of growth factors in cosmetic dermatology. J Clin Aesthet Dermatol. 2011;4(5):30–34. [24] Kim J, Kim WS, Park SH. Conditioned media from stem cells in cosmetic applications. J Cosmet Dermatol. 2013;12(2):96–102. [25] Elsner P, Maibach HI. Cosmeceuticals and active cosmetics. Dermatol Ther. 2005;18(5):402–407. [26] Parolini O, Soncini M. Human placenta-derived stem cells and their potential in regenerative medicine. Stem Cells Dev. 2006;15(5):785–795. [27] Badiavas EV, Falanga V. Treatment of chronic wounds with stem cells. Expert OpinBiol Ther. 2003;3(2):175–182. [28] European Commission. Regulation (EC) No 1223/2009 on cosmetic products. Off J Eur Union. 2009;342:59–209. [29] US Food and Drug Administration. Guidance for industry: cosmetic safety. FDA. 2020. [30] Bureau of Indian Standards. Indian standards for cosmetics. BIS. 2016.

Copyright

Copyright © 2026 Shreyash Chaudhari, Sonali K. Shambharkar, Dr. Manoj V. Girase. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.